Labccin V3 Fresh Sanitizer Gel
NDC Package 70812-569-01
Package Information
Labccin V3 Fresh Sanitizer Gel is a . Marketed by Biostech Co., Ltd., this product is identified by NDC 70812-569 and is authorized under FDA application part333A.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70812 - Biostech Co., Ltd.
- 70812-569 - Labccin V3 Fresh Sanitizer Gel
- 70812-569-01 - 500 mL in 1 BOTTLE, PUMP
- 70812-569 - Labccin V3 Fresh Sanitizer Gel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70812-569-01 identifies a specific commercial package of 500 ml in 1 bottle, pump of Labccin V3 Fresh Sanitizer Gel, labeled by Biostech Co., Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Biostech Co., Ltd. on April 06, 2020. The current certification is valid through September 04, 2023.
How is this Biostech Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70812056901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.